A Proud Member of BIO

    

 

 

 

 

Investor Relations :: Compensation Committee Charter

Compensation Committee Charter

COMPOSITION
 
  1. Composition. The board of directors (the "Board") of La Jolla Pharmaceutical Company (the "Company") shall appoint and maintain a Compensation Committee (the "Committee") composed of at least two independent directors of the Company. The independence of the directors on the Committee shall be determined by the Board in accordance with applicable NASD listing standards. In addition, (i) if any compensation or benefit plan administered by the Committee is subject to Rule 16b-3 of the Securities Act of 1934, as amended, each Committee member shall also be a "non-employee director" as such term is defined in Rule 16b-3 and (ii) if an award or payment under any compensation or benefit plan administered by the Committee would be subject to the deduction limitation under Section 162(m) of the Internal Revenue Code of 1986, as amended, at least two members of the Committee shall also be "outside directors" as such term is defined in Section 162(m) and the regulations promulgated thereunder. The chairperson of the Committee shall be appointed by the Board.
 
  2. Meetings. The Committee will meet as often as may be deemed necessary or appropriate in its judgment, either in person or telephonically, and at such times and places as the Committee shall determine. The Committee shall report regularly to the full Board with respect to its meetings. The majority of the members of the Committee shall constitute a quorum.
 
  3. Outside Advisors. The Committee shall have the authority to retain such outside advisors and experts as it determines appropriate to assist it in the full performance of its functions, including the authority, without further authorization from the Board, to retain (and determine the terms of retention), compensate and terminate any compensation consultant used to assist the committee in the evaluation of director, chief executive officer or other executive compensation.
 
  4. Subcommittees. The Committee may delegate its powers, duties or responsibilities to a subcommittee of the Committee consisting of not less than two members of the Committee.
 
PURPOSE and DUTIES
 
  The purpose of the Committee shall be to assist the Board to discharge its responsibilities regarding the compensation of the Company's employees (including officers) and directors and to prepare the annual report on compensation for inclusion in the Company's annual proxy statement. In furtherance of the foregoing purpose, the duties of the Committee are to:
 
  1. Make recommendations to the Board regarding the corporate goals and objectives relevant to CEO compensation, evaluate the CEO's performance in light of such goals and objectives, and recommend the CEO's compensation level to the Board based on such evaluation.
 
  2. Make recommendations to the Board regarding the corporate goals and objectives relevant to officer compensation (other than the CEO), evaluate such officers' performance in light of such goals and objectives, and recommend the officers' compensation levels to the Board based on this evaluation. The Committee may, in its sole discretion, permit the CEO to be present during these deliberations.
 
  3. Review at least annually director compensation and benefits and, if necessary, make recommendations to the Board regarding changes in director compensation.
 
  4. Administer the Company's incentive compensation plans, including its equity-based incentive plans.
 
  5. Examine and make recommendations to the Board with respect to the Company's overall compensation structure, policies, and programs, including, without limitation, salary, incentive, stock, deferred, retirement, and health benefits, and assess whether such programs establish appropriate and adequate incentives.
 
  6. Make recommendations to the Board regarding the creation, amendment, modification, and termination of the Company's compensation and employee benefit plans.
 
  7. Prepare the annual report on compensation for inclusion in the Company's annual proxy statement.
 
  8. Annually evaluate the adequacy of this Charter and recommend changes to the Board as necessary.
 
  9. Perform such other duties and responsibilities as are consistent with the purpose of the Committee and as the Board or the Committee may deem appropriate.
 
Last Updated: February 25, 2004
 
 
 

Terms of Use & Privacy Policy
Copyright © 2008, La Jolla Pharmaceutical Company










 

 

 

 

 

 

 

 

 

 

 

 

 

Link to conference call